NME1 expression is associated with a bad prognosis and metastasis in renal and bladder cancers [145], leukemia [146,147], hepatocellular carcinoma [148], squamous cell lung carcinoma [149], ovarian cancer [150], and prostate cancer [151]. This evidence concerns the gene NME1 and ovarian cancer.